TY - JOUR
T1 - Italian recommendations for influenza and pneumococcal vaccination in adult patients with autoimmune rheumatic diseases
AU - Guerrini, Giulio
AU - Franzetti, Fabio
AU - Giacomelli, Roberto
AU - Meroni, Luca
AU - Riva, Agostino
AU - Scirè, Carlo Alberto
AU - Scrivo, Rossana
AU - Tavio, Marcello
AU - Agostinone, Adriana
AU - Airò, Paolo
AU - Atzeni, Fabiola
AU - Bartalesi, Filippo
AU - Bazzichi, Laura
AU - Berardicurti, Onorina
AU - Cassola, Giovanni
AU - Castagna, Antonella
AU - Castelli, Francesco
AU - Cattelan, Annamaria
AU - Citriniti, Giorgia
AU - Cristini, Francesco
AU - De Rosa, Francesco
AU - Fracassi, Elena
AU - Galloway, James
AU - La Paglia, Giuliana Maria Concetta
AU - Moioli, Maria Cristina
AU - Ripamonti, Diego
AU - Saracino, Annalisa
AU - Tani, Chiara
AU - Tascini, Carlo
AU - Tieghi, Tiziana
AU - Tinelli, Marco
AU - Zabotti, Alen
AU - Sarzi-Puttini, Piercarlo
AU - Galli, Massimo
N1 - Copyright:
This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine
PY - 2020/3/1
Y1 - 2020/3/1
N2 - OBJECTIVES: To provide evidence-based recommendations for vaccination against influenza virus and S. pneumoniae in patients with autoimmune rheumatic diseases (ARDs). METHODS: A Consensus Committee including physicians with expertise in rheumatic and infectious diseases was established by two Italian scientific societies, Società Italiana di Reumatologia (SIR) and Società Italiana di Malattie Infettive e Tropicali (SIMIT). The experts were invited to develop evidence-based recommendations concerning vaccinations in ARDs patients, based on their clinical status before and after undergoing immunosuppressive treatments. Key clinical questions were formulated for the systematic literature reviews, based on the clinical pathway. A search was made in Medline (via PubMed) according to the original MeSH strategy from October 2009 and a keyword strategy from January 2016 up to December 2017, updating existing EULAR recommendations. Specific recommendations were separately voted and scored from 0 (no agreement with) to 100 (maximal agreement) and supporting evidence graded. The mean and standard deviation of the scores were calculated to determine the level of agreement among the experts' panel for each recommendation. Total cumulative agreement ≥70 defined consensus for each statement. RESULTS: Nine recommendations, based on 6 key clinical questions addressed by the expert committee, were proposed. The aim of this work is to integrate the 2011 EULAR recommendations on vaccination against influenza and S. pneumoniae in ARDs patients. An implementation plan was proposed to improve the vaccination status of these patients and their safety during immunosuppressive treatments. CONCLUSIONS: Influenza and pneumococcus vaccinations are effective and safe in patients with ARDs. More efforts should be made to translate the accumulated evidence into practice.
AB - OBJECTIVES: To provide evidence-based recommendations for vaccination against influenza virus and S. pneumoniae in patients with autoimmune rheumatic diseases (ARDs). METHODS: A Consensus Committee including physicians with expertise in rheumatic and infectious diseases was established by two Italian scientific societies, Società Italiana di Reumatologia (SIR) and Società Italiana di Malattie Infettive e Tropicali (SIMIT). The experts were invited to develop evidence-based recommendations concerning vaccinations in ARDs patients, based on their clinical status before and after undergoing immunosuppressive treatments. Key clinical questions were formulated for the systematic literature reviews, based on the clinical pathway. A search was made in Medline (via PubMed) according to the original MeSH strategy from October 2009 and a keyword strategy from January 2016 up to December 2017, updating existing EULAR recommendations. Specific recommendations were separately voted and scored from 0 (no agreement with) to 100 (maximal agreement) and supporting evidence graded. The mean and standard deviation of the scores were calculated to determine the level of agreement among the experts' panel for each recommendation. Total cumulative agreement ≥70 defined consensus for each statement. RESULTS: Nine recommendations, based on 6 key clinical questions addressed by the expert committee, were proposed. The aim of this work is to integrate the 2011 EULAR recommendations on vaccination against influenza and S. pneumoniae in ARDs patients. An implementation plan was proposed to improve the vaccination status of these patients and their safety during immunosuppressive treatments. CONCLUSIONS: Influenza and pneumococcus vaccinations are effective and safe in patients with ARDs. More efforts should be made to translate the accumulated evidence into practice.
UR - http://www.scopus.com/inward/record.url?scp=85082542739&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082542739&partnerID=8YFLogxK
M3 - Article
C2 - 31498077
AN - SCOPUS:85082542739
VL - 38
SP - 245
EP - 256
JO - Clinical and Experimental Rheumatology
JF - Clinical and Experimental Rheumatology
SN - 0392-856X
IS - 2
ER -